WeVote
Log In

Bill

Bill

HB 75

Medical cannabis; administration to terminally ill patients, report.

2026 Regular Session Introduced by Karen Keys-Gamarra and 1 co-sponsor

HB 75 expands Virginia medical cannabis access for terminally ill patients in licensed medical facilities, potentially easing end-of-life symptom management.

Acts of Assembly Chapter text (CHAP0555)
0
WeVote Research Nonpartisan
Bill Summary · HB 75

Legislative bill overview

HB 75 expands access to medical cannabis for terminally ill patients in Virginia's medical care facilities. The bill modifies existing regulations to allow qualified patients with terminal diagnoses to access cannabis products through approved medical channels, likely streamlining the approval process or eligibility requirements for this patient population.

Why is this important

Terminally ill patients often experience severe pain, nausea, and other symptoms that existing treatments may not adequately manage. This bill addresses end-of-life care quality by potentially offering an additional therapeutic option, while also testing Virginia's regulatory framework for medical cannabis in controlled healthcare settings.

Potential points of contention

  • Federal-state legal conflict: Cannabis remains a Schedule I controlled substance federally, creating compliance and liability questions for Virginia medical facilities despite state authorization
  • Eligibility and oversight: Unclear definitions of "terminally ill," timeline requirements, and which medical professionals can authorize cannabis may create implementation disputes
  • Medical evidence standards: Healthcare providers may debate whether sufficient clinical evidence supports cannabis for terminal care compared to established palliative treatments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.